Abstract:Background Emerging evidence indicates that the mobilization and recruitment of circulating or tissue-resident stem/progenitor cells give rise to smooth muscle cells (SMCs) which participate in numerous cardiovascular diseases. Understanding the regulatory mechanisms that control SMC differentiation and their recruitment from vascular progenitors is essential for stem cell therapy for vascular diseases and regenerative medicine. Hyaluronan (HA) is a linear glycosominoglycan and ubiquitous component of the intercellular matrix; the identification of HA as a critical component of the stem cell niche led us to investigate its role in regulating stem cell differentiation. Methods and Results Stem cells were seeded on collagen-IV-coated flasks and cultured in differentiation medium to induce SMC differentiation as demonstrated by the expression of SMC-specific genes smooth muscle α-actin, calponin, SM22-α and smooth muscle myosin heavy chain. These phenotypic changes coincided with dynamic changes in HA synthesis and organization. It was demonstrated that SMC differentiation was associated with increased HA synthase (HAS)2 expression, extracellular HA synthesis and loss of pericellular HA. Inhibition of HA synthesis by hyaluronidase, 4-methylumbelliferone (4MU), or specific gene silencing of HAS2 led to abrogation of SMC marker expression. Furthermore, It was found that SMC differentiation was coupled to phosphorylation of the EGF-receptor and ERK1/2, this was shown to be HA-dependent as pre-treatment with 4MU prevented downstream events. Paradoxically, when applied exogenously as a culture medium supplement, low molecular weight HA promotes, whereas high molecular weight HA attenuates SMC differentiation. Subsequently, using a bioreactor system, low molecular weight HA was circulated through a decellurised vessel scaffold ex vivo. In contrast to differentiation medium alone the addition of low molecular weight HA promoted migration of stem cells seeded around the outside of the vessel into the media and their differentiation into SMCs, which coincided with localisation of HA and its receptor CD44. Conclusions We demonstrate for the first time that endogenously produced HA is critical for SMC differentiation from stem cells, via activation of EGF-R and ERK1/2. The prospect of maintaining stemness or inducing differentiation in stem cells by manipulation of HA concentration/molecular weight, or by targeting genes activated by HA, may provide new therapies for vascular disease.

ROLE OF HYALURONAN IN PATHOPHYSIOLOGY OF VASCULAR1 ENDOTHELIAL AND SMOOTH MUSCLE CELLS.

Role of Hyaluronic acid and its chemical derivatives in immunity during homeostasis, cancer and tissue regeneration

Plasma Hyaluronan and Collateral Development in Patients with Coronary Artery Disease

Hyaluronan is Crucial for Stem Cell Differentiation into Smooth Muscle Lineage

Hyaluronic Acid Role in Biomaterials Prevascularization

198 HYALURONAN IS REQUIRED FOR SMOOTH MUSCLE CELL DIFFERENTIATION FROM STEM CELLS

The Role of Hyaluronic Acid

Hyaluronic Acid: Redefining Its Role

The roles of hyaluronan in kidney development, physiology and disease

'Two-faces' of hyaluronan, a dynamic barometer of disease progression in tumor microenvironment

Vascular Extracellular Matrix in Atherosclerosis

Hyaluronan in Adipose Tissue, Metabolic Inflammation, and Diabetes: Innocent Bystander or Guilty Party?

The Importance of Hyaluronic Acid in Biological Systems

The dynamic vasa vasorum

The effects of 4-methylumbelliferone on hyaluronan synthesis, MMP2 activity, proliferation, and motility of human aortic smooth muscle cells

Hyaluronan and Hyaluronan Fragments

Hyaluronidases in Human Diseases

Hyaluronan homeostasis and its role in pain and muscle stiffness

Hyaluronan Provokes Inflammation but Suppresses Phagocytotic Function in Macrophages

Cell Energy Metabolism and Hyaluronan Synthesis

Microrheology of hyaluronan solutions: implications for the endothelial glycocalyx